<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Lab2BIOTECH]]></title><description><![CDATA[Lab2BIOTECH provides operational support for research and development and business development activities in oncology and Neuro-Oncology for biotechs.]]></description><link>https://www.lab2biotech.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Wed, 17 Jun 2026 14:01:55 GMT</lastBuildDate><atom:link href="https://www.lab2biotech.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[POSTER on socioeconomic Burden of Glioblastoma in the US and Europe: Treatment Costs, Underestimated Indirect Costs, and Caregiver Burden]]></title><description><![CDATA[ENGLISH VERSION --- POSTER, ANOCEF 2026 meeting (Dijon, June 18–20th)--- TITLE: Socioeconomic Burden of Glioblastoma in the US and Europe: Treatment Costs, Underestimated Indirect Costs, and Caregiver Burden Subtitle: A Literature- and Field-Based Analysis to Inform Future Research Directions   AUTHORS and affiliation: · Courtès Sandrine, Lab2BIOTECH (1rst and corresponding author) · Ma Cuiying, Syneos London  · Bianic Florence, Syneos Paris   ABSTRACT   Background: Glioblastoma [GBM] is the...]]></description><link>https://www.lab2biotech.com/post/poster-on-socioeconomic-burden-of-glioblastoma-in-the-us-and-europe-treatment-costs-underestimated</link><guid isPermaLink="false">6a2d62ef00dbe48b1c772874</guid><pubDate>Sat, 13 Jun 2026 14:51:47 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/3eb053_6b7dfee752e74b40a37c3aa02f02e2a3~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Courtès Sandrine, PhD</dc:creator></item></channel></rss>